Last reviewed · How we verify

NCT06158074

Efficacy of Electrical Pudendal Nerve Stimulation and Sacral in Treating Non-obstructive Neurogenic Urinary Retention

Completed NA Last updated 16 September 2025
What this trial tests

NA trial testing electrical pudendal nerve stimulation in Urinary Retention in 70 participants. Completed in 31 December 2024.

Timeline
1 January 2024
Primary endpoint
30 November 2024
31 December 2024

Quick facts

Lead sponsorShanghai Institute of Acupuncture, Moxibustion and Meridian
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment70
Start date1 January 2024
Primary completion30 November 2024
Estimated completion31 December 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Shanghai Institute of Acupuncture, Moxibustion and Meridian

Who can join

Adults 18 to 85, any sex, with Urinary Retention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To observe the clinical effects and make a comparative study between efficacy of electrical pudendal nerve stimulation (EPNS) and sacral neuromodulation (SNM) , evaluate the advantages of EPNS in the treatment of neurogenic non-obstructive urinary retention, and provide a new method for the treatment of the disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of electrical pudendal nerve stimulation

Trials testing the same drug.

Other recruiting trials for Urinary Retention

Currently open trials in the same condition.

Other Shanghai Institute of Acupuncture, Moxibustion and Meridian trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06158074.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing